These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

737 related articles for article (PubMed ID: 20138330)

  • 1. Reappraisal of mesenchymal chondrosarcoma: novel morphologic observations of the hyaline cartilage and endochondral ossification and beta-catenin, Sox9, and osteocalcin immunostaining of 22 cases.
    Fanburg-Smith JC; Auerbach A; Marwaha JS; Wang Z; Rushing EJ
    Hum Pathol; 2010 May; 41(5):653-62. PubMed ID: 20138330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sox9, a master regulator of chondrogenesis, distinguishes mesenchymal chondrosarcoma from other small blue round cell tumors.
    Wehrli BM; Huang W; De Crombrugghe B; Ayala AG; Czerniak B
    Hum Pathol; 2003 Mar; 34(3):263-9. PubMed ID: 12673561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of matrilin-3 not only in osteoarthritic articular cartilage but also in cartilage-forming tumors, and down-regulation of SOX9 via epidermal growth factor domain 1-dependent signaling.
    Vincourt JB; Vignaud JM; Lionneton F; Sirveaux F; Kawaki H; Marchal S; Lomazzi S; Plénat F; Guillemin F; Netter P; Takigawa M; Mainard D; Magdalou J
    Arthritis Rheum; 2008 Sep; 58(9):2798-808. PubMed ID: 18759284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoprofile of mesenchymal chondrosarcoma: aberrant desmin and EMA expression, retention of INI1, and negative estrogen receptor in 22 female-predominant central nervous system and musculoskeletal cases.
    Fanburg-Smith JC; Auerbach A; Marwaha JS; Wang Z; Santi M; Judkins AR; Rushing EJ
    Ann Diagn Pathol; 2010 Feb; 14(1):8-14. PubMed ID: 20123451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOX9 is a major negative regulator of cartilage vascularization, bone marrow formation and endochondral ossification.
    Hattori T; Müller C; Gebhard S; Bauer E; Pausch F; Schlund B; Bösl MR; Hess A; Surmann-Schmitt C; von der Mark H; de Crombrugghe B; von der Mark K
    Development; 2010 Mar; 137(6):901-11. PubMed ID: 20179096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NKX3.1 a useful marker for mesenchymal chondrosarcoma: An immunohistochemical study.
    Syed M; Mushtaq S; Loya A; Hassan U
    Ann Diagn Pathol; 2021 Feb; 50():151660. PubMed ID: 33302222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis.
    Day TF; Guo X; Garrett-Beal L; Yang Y
    Dev Cell; 2005 May; 8(5):739-50. PubMed ID: 15866164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal chondrosarcoma: clinicopathologic study of 20 cases.
    Shakked RJ; Geller DS; Gorlick R; Dorfman HD
    Arch Pathol Lab Med; 2012 Jan; 136(1):61-75. PubMed ID: 22208489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinicopathologic and immunohistochemical study of 23 cases of mesenchymal chondrosarcoma].
    Pang ZG; He XZ; Wu LY; Wei W; Liu XY; Liao DY; Li FY; Zhang XL
    Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):368-72. PubMed ID: 21914343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaline cartilage formation and enchondral ossification modeled with KUM5 and OP9 chondroblasts.
    Sugiki T; Uyama T; Toyoda M; Morioka H; Kume S; Miyado K; Matsumoto K; Saito H; Tsumaki N; Takahashi Y; Toyama Y; Umezawa A
    J Cell Biochem; 2007 Apr; 100(5):1240-54. PubMed ID: 17115412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal chondrosarcoma: a clinicopathologic and flow cytometric study of 13 cases presenting in the central nervous system.
    Rushing EJ; Armonda RA; Ansari Q; Mena H
    Cancer; 1996 May; 77(9):1884-91. PubMed ID: 8646689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic tensile strain facilitates the ossification of ligamentum flavum through β-catenin signaling pathway: in vitro analysis.
    Cai HX; Yayama T; Uchida K; Nakajima H; Sugita D; Guerrero AR; Yoshida A; Baba H
    Spine (Phila Pa 1976); 2012 May; 37(11):E639-46. PubMed ID: 22158061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus mediated BMP-13 gene transfer induces chondrogenic differentiation of murine mesenchymal progenitor cells.
    Nochi H; Sung JH; Lou J; Adkisson HD; Maloney WJ; Hruska KA
    J Bone Miner Res; 2004 Jan; 19(1):111-22. PubMed ID: 14753743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secreted frizzled related protein 1 regulates Wnt signaling for BMP2 induced chondrocyte differentiation.
    Gaur T; Rich L; Lengner CJ; Hussain S; Trevant B; Ayers D; Stein JL; Bodine PV; Komm BS; Stein GS; Lian JB
    J Cell Physiol; 2006 Jul; 208(1):87-96. PubMed ID: 16575902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunohistochemical localization of bone Gla protein and osteonectin in normal human bone and cartilage tissues, and in osteosarcomas and chondrosarcomas].
    Chiba H; Matsuyama T
    Nihon Seikeigeka Gakkai Zasshi; 1993 May; 67(5):463-72. PubMed ID: 8336066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cartilage-specific transcription factor Sox9 regulates AP-2epsilon expression in chondrocytes.
    Wenke AK; Grässel S; Moser M; Bosserhoff AK
    FEBS J; 2009 May; 276(9):2494-504. PubMed ID: 19476490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletogenesis in Xenopus tropicalis: characteristic bone development in an anuran amphibian.
    Miura S; Hanaoka K; Togashi S
    Bone; 2008 Nov; 43(5):901-9. PubMed ID: 18692165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sox9 expression is not limited to chondroid neoplasms: variable occurrence in other soft tissue and bone tumors with frequent expression by synovial sarcomas.
    Cajaiba MM; Jianhua Luo ; Goodman MA; Fuhrer KA; Rao UN
    Int J Surg Pathol; 2010 Oct; 18(5):319-23. PubMed ID: 20484142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic pitfall in the diagnosis of mesenchymal chondrosarcoma arising in the central nervous system.
    Lin L; Varikatt W; Dexter M; Ng T
    Neuropathology; 2012 Feb; 32(1):82-90. PubMed ID: 21615516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal chondrosarcoma: an immunohistochemical study of 10 cases examining prognostic significance of proliferative activity and cellular differentiation.
    Nussbeck W; Neureiter D; Söder S; Inwards C; Aigner T
    Pathology; 2004 Jun; 36(3):230-3. PubMed ID: 15203726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.